The Chemiluminescence Immunoassay Market was valued at USD 12.6 billion in 2023 and will surpass USD 20.2 billion by 2030; growing at a CAGR of 7.0% during 2024 - 2030. Chemiluminescence Immunoassay is a biochemical method used to detect and measure the concentration of various analytes in blood or other bodily fluids. It is widely used for diagnosing diseases by identifying specific...

Chemiluminescence Immunoassay (CLIA) is a cutting-edge diagnostic    technique that leverages the principles  of chemiluminescence  and immunoassay to detect and quantify ...